Showing results (61-70 of 2,329) with videos related to

Sort By:
Pageof 233
Clinical Drug Investigation|March 9, 2019
Benefits of Beta-Blockade in Sepsis and Septic Shock: A Systematic ReviewYoung R Lee, Michael Sadanand Seth, Dylan Soney, et al.
Clinical Drug Investigation|February 19, 2021
Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile InfectionThomas P Lodise, Rohit Mistry, Kate Young, et al.
Clinical Drug Investigation|February 23, 2017
Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?Christiane Michel, Emil Scosyrev, Michael Petrin, et al.
Clinical Drug Investigation|March 2, 2017
Efficacy of Daily Teriparatide Treatment in Low Levels of Walking State PatientsRui Niimi, Toshibumi Kono, Atsushi Nishihara, et al.
Clinical Drug Investigation|August 22, 2019
Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet BioavailabilityHaiyan Li, Yudong Wei, Shuang Zhang, et al.
Clinical Drug Investigation|April 15, 2008
Stroke risk screening of adults with hypertension: prospective cross-sectional study in primary careKurt Bestehorn, Klaus Wahle, W Kirch
Clinical Drug Investigation|May 16, 2008
Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response studyClive Wilder-Smith, Anna Backlund, Göran Eckerwall, et al.
Clinical Drug Investigation|May 16, 2008
Comparative bioavailability of lornoxicam as single doses of quick-release tablet, standard tablet and intramuscular injection: a randomized, open-label, crossover phase I study in healthy volunteersSusanna Radhofer-Welte, Peter Dittrich, Marija Simin, et al.
Clinical Drug Investigation|May 16, 2008
Current and future antiretroviral treatment options in paediatric HIV infectionCarlo Giaquinto, Erika Morelli, Federica Fregonese, et al.
Clinical Drug Investigation|March 29, 2008
Pharmacoeconomic assessment of olanzapine in the treatment of refractory schizophrenia based on a pilot clinical studyJ A Sacristán, J C Gómez, J Martín, et al.
Pageof 233